DOCSLIB.ORG

ICD-9-CM Official Guidelines for Coding and Reporting Effective October 1, 2002 Narrative Changes Appear in Bold Text

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ICD-9-CM Official Guidelines for Coding and Reporting Effective October 1, 2002 Narrative Changes Appear in Bold Text ICD-9-CM Official Guidelines For Coding and Reporting Effective October 1, 2002 Narrative changes appear in bold text The Centers for Medicare and Medicaid Services (CMS) formerly the Health Care Financing Administration (HCFA) and the National Center for Health Statistics (NCHS), two departments within the Department of Health and Human Services (DHHS) present the following guidelines for coding and reporting using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). These guidelines should be used as a companion document to the official version of the ICD-9-CM as published on CD-ROM. These guidelines for coding and reporting have been developed and approved by the Cooperating Parties for ICD-9-CM: the American Hospital Association, the American Health Information Management Association, CMS, and the NCHS. These guidelines, published by the Department of Health and Human Services have also appeared in the Coding Clinic for ICD-9-CM, published by the American Hospital Association. These guidelines have been developed to assist the user in coding and reporting in situations where the ICD-9-CM does not provide direction. Coding and sequencing instructions in volumes I, II, and III of ICD-9-CM take precedence over any guidelines. The conventions, general guidelines and chapter-specific guidelines apply to the proper use of ICD-9-CM, regardless of the health care setting. A joint effort between the attending physician and coder is essential to achieve complete and accurate documentation, code assignment, and reporting of diagnoses and procedures. These guidelines have been developed and approved by the Cooperating Parties to assist both the physician and the coder in identifying those diagnoses that are to be reported. The importance of consistent, complete documentation in the medical record cannot be overemphasized. Without such documentation the application of all coding guidelines is a difficult, if not impossible, task. These guidelines are not exhaustive. The cooperating parties are continuing to conduct reviews of these guidelines and develop new guidelines as needed. Users of the ICD-9-CM should be aware that only guidelines approved by the cooperating parties are official. Revision of these guidelines and new guidelines will be published by the U.S. Department of Health and Human Services when they are approved by the cooperating parties. The term “admitted” is used generally to mean a health care encounter in any setting. The guidelines have been reorganized into several new sections including an enhanced introduction that provides more detail about the structure and conventions of the classification usually found in the classification itself. The other new section, General Guidelines, brings together overarching guidelines that were previously found throughout the various sections of the guidelines. The new format of the guidelines also includes a resequencing of the disease-specific guidelines. They are sequenced in the same order as they appear in the tabular list chapters (Infectious and Parasitic diseases, Neoplasms, etc.) These changes will make it easier for coders, experienced and beginners, to more easily find the specific portion of the coding guideline information they seek. Page 1 of 52 Table of Contents Section I ICD-9-CM Conventions, General Coding Guidelines and Chapter-specific Guidelines A. ICD-9-CM conventions Conventions of the ICD-9-CM Abbreviations Etiology/manifestation convention Format Includes and Excludes Notes and Inclusion Terms Other and Unspecified Codes Punctuation B. General Coding Guidelines Acute and Chronic Conditions Combination Codes Conditions that are integral part of disease Conditions that are not integral part of disease Impending or Threatened Conditions Late Effects Level of Detail in Coding Multiple Coding of Single Conditions Signs and Symptoms Other and Unspecified (NOS) Code Titles Other Multiple Coding for Single Condition Code, if applicable Use additional code Use of Alphabetic Index and Tabular List C. Chapter-specific Guidelines C1.Infectious and Parasitic diseases A. Human Immunodeficiency Virus (HIV) Infections Asymptomatic HIV Infection Confirmed Cases of HIV Infection/Illness HIV Infection in Pregnancy, Childbirth and the Puerperium Inconclusive Lab Test for HIV Previously Diagnosed HIV-related Illness Selection and Sequencing of HIV Code Testing for HIV B. Septicemia and Shock C2.Neoplasms Page 2 of 52 C3.Endocrine, Nutritional, and Metabolic Diseases and Immunity Disorders Reserved for future guidelines expansion C4.Diseases of Blood and Blood Forming Organs Reserved for future guideline expansion C5.Mental Disorders Reserved for future guideline expansion C6.Diseases of Nervous System and Sense Organs Reserved for future guideline expansion C7.Diseases of Circulatory System A. Hypertension Controlled Hypertension Elevated Blood Pressure Essential Hypertension Hypertension with Heart Disease Hypertensive Cerebrovascular Disease Hypertensive Heart and Renal Disease Hypertensive Renal Disease with Chronic Renal Failure Hypertensive Retinopathy Secondary Hypertension Transient Hypertension Uncontrolled Hypertension B. Late Effect of Cerebrovascular Accident C8.Diseases of Respiratory System Reserved for future guideline expansion C9.Diseases of Digestive System Reserved for future guideline expansion C10.Diseases of Genitourinary System Reserved for future guideline expansion C11.Complications of Pregnancy, Childbirth, and the Puerperium Abortions Chapter 11 Fifth-digits Fetal Conditions Affecting Management of Mother General Rules HIV Infection in Pregnancy, Childbirth and Puerperium Late Effects of Complications of Pregnancy, Childbirth and the Puerperium Normal Delivery 650 Postpartum Period Selection of Principal Diagnosis Page 3 of 52 C12.Diseases Skin and Subcutaneous Tissue Reserved for future guideline expansion C13.Diseases of Musculoskeletal and Connective Tissue Reserved for future guideline expansion C14.Congenital Anomalies Reserved for future guideline expansion C15. Certain Conditions Originating in the Newborn (Perinatal) Period Clinically Significant Conditions Congenital Anomalies General Perinatal Rule Maternal Causes of Perinatal Morbidity Newborn Transfers Other (Additional) Diagnoses Prematurity and Fetal Growth Retardation Use of Category V29 Use of Codes V30-V39 C16.Signs, Symptoms and Ill-Defined Conditions Reserved for future guideline expansion C17.Injury and Poisoning Adverse Effect Adverse Effects, Poisonings and Toxic Effects Coding of Fractures Coding of Injuries Coding of Burns Coding of Debridement of Wound, Infection or Burn Coding of Adverse Effects, Poisoning and Toxic Effects C18.Supplemental Classification of Factors Influencing Health Status and Contact with Health Service (V-Codes) 1. Contact/Exposure 2. Inoculations and vaccinations 3. Status 4. History (of) 5. Screening 6. Observation 7. Aftercare 8. Follow-up 9. Donor 10. Counseling 11. Obstetrics 12. Newborn, infant and child 13. Routine and administrative examinations Page 4 of 52 14. Miscellaneous V codes 15. Nonspecific V codes C19.Supplemental Classification of External Causes of Injury and Poisoning Child and Adult Abuse General Coding guidelines Late effects Misadventures and complications of care Multiple external causes Place of occurrence Poisonings and adverse effects of drugs Terrorism Undetermined cause Unknown intent Section II Selection of Principal Diagnosis(es) for Inpatient, Short-term, Acute Care Hospital Records Complications of Surgery and Other Medical Care Original Treatment Plan Not Carried Out Symptoms, Signs, and Ill-defined Conditions Symptom Followed by Contrasting/Comparative Diagnoses Two or More Comparative or Contrasting Conditions Two or More Equally Meet Definition Two or More Interrelated Conditions Uncertain Diagnosis Section III Reporting Additional Diagnoses for Inpatient, Short-term, Acute Care Hospital Records Abnormal Findings General Rules Previous Conditions Uncertain Diagnosis Section IV Diagnostic Coding and Reporting Guidelines for Outpatient Services Page 5 of 52 Section I Conventions, General Coding Guidelines and Chapter-Specific Guidelines The conventions, general guidelines and chapter-specific guidelines are applicable to all health care settings unless otherwise indicated. A. Conventions for the ICD-9-CM The conventions for the ICD-9-CM are the general rules for use of the classification independent of the guidelines. These conventions are incorporated within the index and tabular of the ICD-9-CM as instructional notes. The conventions are as follows: 1. Format: The ICD-9-CM uses an indented format for ease in reference 2. Abbreviations a. Index Abbreviations NEC “Not elsewhere classifiable” This abbreviation in the index represents “other specified” When a specific code is not available for a condition the index directs the coder to the “other specified” code in the tabular. b. Tabular Abbreviations NEC “Not elsewhere classifiable” This abbreviation in the tabular represents “other specified” When a specific code is not available for a condition the tabular includes an NEC entry under a code to identify the code as the “other specified” code. (see “Other” codes) NOS “Not otherwise specified” This abbreviation is the equivalent of unspecified. (see “Unspecified” codes) 3. Punctuation [ ] Brackets are used in the tabular list to enclose synonyms, alternative wording or explanatory phrases. Brackets are used in the index to identify manifestation codes. (see etiology/manifestations)
Load more

Recommended publications
  • Laparoscopy As a Diagnostic Tool in Ascites of Unknown Origin: a Retrospective Study Conducted at Kasturba Hospital, Manipal
    Research Article Open Access J Surg Volume 8 Issue 3 - March 2018 Copyright © All rights are reserved by Chetan R Kulkarni DOI: 10.19080/OAJS.2018.08.555740 Laparoscopy as a Diagnostic Tool in Ascites of Unknown Origin: A Retrospective Study Conducted at Kasturba Hospital, Manipal Chetan R Kulkarni1*, Badareesh Laxminarayan2 and Annappa Kudva3 1Assistant Professor, Department of Surgery, Kasturba Hospital, Manipal 2Associate Professor, Department of Surgery, Kasturba Hospital, Manipal 3Professor, Department of Surgery, Kasturba Hospital, Manipal Received: February 16, 2018; Published: March 01, 2018 *Corresponding author: Chetan R Kulkarni, Assistant Professor, Department of Surgery, Kasturba Hospital, Manipal, India. Tel: 9535974395;Email: Abstract Background: Laparoscopy as a minimally invasive technique has long played an important role in the evaluation of ascites. Methods: A retrospective analysis was carried out on the record of 80patients who underwent laparoscopy after appropriate investigations had failed to reveal the cause of ascites. Results: Tuberculous peritonitis was reported in 46(57%), malignancies in 18(25%), cirrhosis in 4(5%) and peritonitis of unknown etiology in 8(10%)Conclusion: of patients. Two (2.5%) patients had complications, an Ileal perforation and in other Incisional hernia. Keywords: Ascites;Laparoscopy Diagnostic was Laparoscopy able to diagnose the pathology in 72 (90%) patients with ascites of unknown origin. Introduction Laparoscopy, as a minimally invasive technique has developed rapidly in recent years. Endoscopic examination of conventional laboratory examinations (including ascitic fluid cell count, albumin level, total protein level, Gram stain, culture who termed it as “Celioscopy” [1,2]. The term ‘ascites’ refers to and cytology ) as well as after imaging investigations (including peritoneal cavity was first attempted in 1901 by George Kelling Materialultrasound andand CT Methods scan).
    [Show full text]
  • Presence of ROS in Inflammatory Environment of Peri-Implantitis Tissue
    Journal of Clinical Medicine Article Presence of ROS in Inflammatory Environment of Peri-Implantitis Tissue: In Vitro and In Vivo Human Evidence 1, 2, 2, 3 4 Eitan Mijiritsky y, Letizia Ferroni y, Chiara Gardin y, Oren Peleg , Alper Gultekin , Alper Saglanmak 4, Lucia Gemma Delogu 5, Dinko Mitrecic 6, Adriano Piattelli 7, 8, 2,9, , Marco Tatullo z and Barbara Zavan * z 1 Head and Neck Maxillofacial Surgery, Department of Otoryngology, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Weizmann street 6, 6423906 Tel-Aviv, Israel; [email protected] 2 Maria Cecilia Hospital, GVM Care & Research, Cotignola, 48033 Ravenna, Italy; [email protected] (L.F.); [email protected] (C.G.) 3 Department of Otolaryngology Head and Neck Surgery and Maxillofacial Surgery, Tel-Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, 701990 Tel-Aviv, Israel; [email protected] 4 Istanbul University, Faculty of Dentistry, Department of Oral Implantology, 34093 Istanbul, Turkey; [email protected] (A.G.); [email protected] (A.S.) 5 University of Padova, DpT Biomedical Sciences, 35133 Padova, Italy; [email protected] 6 School of Medicine, Croatian Institute for Brain Research, University of Zagreb, Šalata 12, 10 000 Zagreb, Croatia; [email protected] 7 Department of Medical, Oral, and Biotechnological Sciences, University of Chieti-Pescara, via dei Vestini 31, 66100 Chieti, Italy; [email protected] 8 Marrelli Health-Tecnologica Research Institute, Biomedical Section, Street E. Fermi, 88900 Crotone, Italy; [email protected] 9 Department of Medical Sciences, University of Ferrara, via Fossato di Mortara 70, 44123 Ferara, Italy * Correspondence: [email protected] Co-first author.
    [Show full text]
  • Clinical Practice Guideline for Limb Salvage Or Early Amputation
    Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline Adopted by: The American Academy of Orthopaedic Surgeons Board of Directors December 6, 2019 Endorsed by: Please cite this guideline as: American Academy of Orthopaedic Surgeons. Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline. https://www.aaos.org/globalassets/quality-and-practice-resources/dod/ lsa-cpg-final-draft-12-10-19.pdf Published December 6, 2019 View background material via the LSA CPG eAppendix Disclaimer This clinical practice guideline was developed by a physician volunteer clinical practice guideline development group based on a formal systematic review of the available scientific and clinical information and accepted approaches to treatment and/or diagnosis. This clinical practice guideline is not intended to be a fixed protocol, as some patients may require more or less treatment or different means of diagnosis. Clinical patients may not necessarily be the same as those found in a clinical trial. Patient care and treatment should always be based on a clinician’s independent medical judgment, given the individual patient’s specific clinical circumstances. Disclosure Requirement In accordance with AAOS policy, all individuals whose names appear as authors or contributors to this clinical practice guideline filed a disclosure statement as part of the submission process. All panel members provided full disclosure of potential conflicts of interest prior to voting on the recommendations contained within this clinical practice guideline. Funding Source This clinical practice guideline was funded exclusively through a research grant provided by the United States Department of Defense with no funding from outside commercial sources to support the development of this document.
    [Show full text]
  • Overview of Biomaterials and Their Use in Medical Devices
    © 2003 ASM International. All Rights Reserved. www.asminternational.org Handbook of Materials for Medical Devices (#06974G) CHAPTER 1 Overview of Biomaterials and Their Use in Medical Devices A BIOMATERIAL, as defined in this hand- shapes, have relatively low cost, and be readily book, is any synthetic material that is used to available. replace or restore function to a body tissue and Figure 1 lists the various material require- is continuously or intermittently in contact with ments that must be met for successful total joint body fluids (Ref 1). This definition is somewhat replacement. The ideal material or material restrictive, because it excludes materials used combination should exhibit the following prop- for devices such as surgical or dental instru- erties: ments. Although these instruments are exposed A biocompatible chemical composition to to body fluids, they do not replace or augment • avoid adverse tissue reactions the function of human tissue. It should be noted, Excellent resistance to degradation (e.g., cor- however, that materials for surgical instru- • rosion resistance for metals or resistance to ments, particularly stainless steels, are reviewed biological degradation in polymers) briefly in Chapter 3, “Metallic Materials,” in Acceptable strength to sustain cyclic loading this handbook. Similarly, stainless steels and • endured by the joint shape memory alloys used for dental/endodon- A low modulus to minimize bone resorption tic instruments are discussed in Chapter 10, • High wear resistance to minimize wear- “Biomaterials for Dental Applications.” • debris generation Also excluded from the aforementioned defi- nition are materials that are used for external prostheses, such as artificial limbs or devices Uses for Biomaterials (Ref 3) such as hearing aids.
    [Show full text]
  • Pictures of Central Venous Catheters
    Pictures of Central Venous Catheters Below are examples of central venous catheters. This is not an all inclusive list of either type of catheter or type of access device. Tunneled Central Venous Catheters. Tunneled catheters are passed under the skin to a separate exit point. This helps stabilize them making them useful for long term therapy. They can have one or more lumens. Power Hickman® Multi-lumen Hickman® or Groshong® Tunneled Central Broviac® Long-Term Tunneled Central Venous Catheter Dialysis Catheters Venous Catheter © 2013 C. R. Bard, Inc. Used with permission. Bard, are trademarks and/or registered trademarks of C. R. Bard, Inc. Implanted Ports. Inplanted ports are also tunneled under the skin. The port itself is placed under the skin and accessed as needed. When not accessed, they only need an occasional flush but otherwise do not require care. They can be multilumen as well. They are also useful for long term therapy. ` Single lumen PowerPort® Vue Implantable Port Titanium Dome Port Dual lumen SlimPort® Dual-lumen RosenblattTM Implantable Port © 2013 C. R. Bard, Inc. Used with permission. Bard, are trademarks and/or registered trademarks of C. R. Bard, Inc. Non-tunneled Central Venous Catheters. Non-tunneled catheters are used for short term therapy and in emergent situations. MAHURKARTM Elite Dialysis Catheter Image provided courtesy of Covidien. MAHURKAR is a trademark of Sakharam D. Mahurkar, MD. © Covidien. All rights reserved. Peripherally Inserted Central Catheters. A “PICC” is inserted in a large peripheral vein, such as the cephalic or basilic vein, and then advanced until the tip rests in the distal superior vena cava or cavoatrial junction.
    [Show full text]
  • Coding Billing
    CodingCoding&Billing FEBRUARY 2020 Quarterly Editor’s Letter Welcome to the February issue of the ATS Coding and Billing Quarterly. There are several important updates about the final Medicare rules for 2020 that will be important for pulmonary, critical care and sleep providers. Additionally, there is discussion of E/M documentation rules that will be coming in 2021 that practices might need some time to prepare for, and as always, we will answer coding, billing and regulatory compliance questions submitted from ATS members. If you are looking for a more interactive way to learn about the 2020 Medicare final rules, there is a webinar on the ATS website that covers key parts of the Medicare final rules. But before we get to all this important information, I have a request for your help. EDITOR ATS Needs Your Help – Recent Invoices for Bronchoscopes and PFT Lab ALAN L. PLUMMER, MD Spirometers ATS RUC Advisor TheA TS is looking for invoices for recently purchased bronchoscopes and ADVISORY BOARD MEMBERS: PFT lab spirometer. These invoices will be used by theA TS to present practice KEVIN KOVITZ, MD expense cost equipment to CMS to help establish appropriate reimbursement Chair, ATS Clinical Practice Committee rates for physician services using this equipment. KATINA NICOLACAKIS, MD Member, ATS Clinical Practice Committee • Invoices should not include education or service contract as those ATS Alternate RUC Advisorr are overhead and cannot be considered by CMS for this portion of the STEPHEN P. HOFFMANN, MD Member, ATS Clinical Practice Committee formula and payment rates. ATS CPT Advisor • Invoices can be up to five years old.
    [Show full text]
  • Recurrent Pneumothorax Following Abdominal Paracentesis
    Postgrad Med J (1990) 66, 319 - 320 © The Fellowship of Postgraduate Medicine, 1990 Postgrad Med J: first published as 10.1136/pgmj.66.774.319 on 1 April 1990. Downloaded from Recurrent pneumothorax following abdominal paracentesis P.J. Stafford Department ofMedicine, Newham General Hospital, Glen Road, Plaistow, London E13, UK. Summary: A 62 year old man presented with abdominal ascites, without pleural effusion, due to peritoneal mesothelioma. He had chronic obstructive airways disease and a past history of right upper lobectomy for tuberculosis. On two occasions abdominal paracentesis was followed within 72 hours by pneumothorax. This previously unreported complication of abdominal paracentesis may be due to increased diaphragmatic excursion following the procedure and should be considered in patients with preexisting lung disease. Introduction Abdominal paracentesis is a widely used palliative right iliac fossa. Approximately 4 litres of turbid therapy for malignant ascites and is generally fluid was drained over 72 hours. The protein accepted as a procedure with few adverse effects: concentration was 46 g/l and microbiology and pneumothorax is not a recognized complication. I cytology were not diagnostic. Laparoscopy re- report a patient with recurrent pneumothorax vealed matted loops of bowel with widespread apparently precipitated by abdominal paracen- peritoneal seedlings. Histological examination of copyright. tesis. these lesions showed malignant mesothelioma of the epithelioid type. The patient suffered a left pneumothorax within Case report 48 hours ofparacentesis (before laparoscopy). This was treated with intercostal underwater drainage A 62 year old civil servant presented with a 6-week but recurred on two attempts to remove the drain, history ofworsening abdominal distension.
    [Show full text]
  • Bates' Pocket Guide to Physical Examination and History Taking
    Lynn S. Bickley, MD, FACP Clinical Professor of Internal Medicine School of Medicine University of New Mexico Albuquerque, New Mexico Peter G. Szilagyi, MD, MPH Professor of Pediatrics Chief, Division of General Pediatrics University of Rochester School of Medicine and Dentistry Rochester, New York Acquisitions Editor: Elizabeth Nieginski/Susan Rhyner Product Manager: Annette Ferran Editorial Assistant: Ashley Fischer Design Coordinator: Joan Wendt Art Director, Illustration: Brett MacNaughton Manufacturing Coordinator: Karin Duffield Indexer: Angie Allen Prepress Vendor: Aptara, Inc. 7th Edition Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins. Copyright © 2009 by Wolters Kluwer Health | Lippincott Williams & Wilkins. Copyright © 2007, 2004, 2000 by Lippincott Williams & Wilkins. Copyright © 1995, 1991 by J. B. Lippincott Company. All rights reserved. This book is protected by copyright. No part of this book may be reproduced or transmitted in any form or by any means, including as photocopies or scanned-in or other electronic copies, or utilized by any information storage and retrieval system without written permission from the copyright owner, except for brief quotations embodied in critical articles and reviews. Materials appear- ing in this book prepared by individuals as part of their official duties as U.S. government employees are not covered by the above-mentioned copyright. To request permission, please contact Lippincott Williams & Wilkins at Two Commerce Square, 2001 Market Street, Philadelphia PA 19103, via email at [email protected] or via website at lww.com (products and services). 9 8 7 6 5 4 3 2 1 Printed in China Library of Congress Cataloging-in-Publication Data Bickley, Lynn S. Bates’ pocket guide to physical examination and history taking / Lynn S.
    [Show full text]
  • Information for Patients Having a Sigmoid Colectomy
    Patient information – Pre-operative Assessment Clinic Information for patients having a sigmoid colectomy This leaflet will explain what will happen when you come to the hospital for your operation. It is important that you understand what to expect and feel able to take an active role in your treatment. Your surgeon will have already discussed your treatment with you and will give advice about what to do when you get home. What is a sigmoid colectomy? This operation involves removing the sigmoid colon, which lies on the left side of your abdominal cavity (tummy). We would then normally join the remaining left colon to the top of the rectum (the ‘storage’ organ of the bowel). The lines on the attached diagram show the piece of bowel being removed. This operation is done with you asleep (general anaesthetic). The operation not only removes the bowel containing the tumour but also removes the draining lymph glands from this part of the bowel. This is sent to the pathologists who will then analyse each bit of the bowel and the lymph glands in detail under the microscope. This operation can often be completed in a ‘keyhole’ manner, which means less trauma to the abdominal muscles, as the biggest wound is the one to remove the bowel from the abdomen. Sometimes, this is not possible, in which case the same operation is done through a bigger incision in the abdominal wall – this is called an ‘open’ operation. It does take longer to recover with an open operation but, if it is necessary, it is the safest thing to do.
    [Show full text]
  • Thoracentesis
    The new england journal of medicine videos in clinical medicine Thoracentesis Todd W. Thomsen, M.D., Jennifer DeLaPena, M.D., and Gary S. Setnik, M.D. INDICATIONS From the Department of Emergency Medi- Thoracentesis is a valuable diagnostic procedure in a patient with pleural effusion cine, Mount Auburn Hospital, Cambridge, of unknown causation. Analysis of the pleural fluid will allow its categorization as MA (T.W.T., G.S.S.); the Department of Emergency Medicine, Beth Israel Deacon- either a transudate (a product of unbalanced hydrostatic forces) or an exudate (a ess Medical Center, Boston (J.D.); and the product of increased capillary permeability or lymphatic obstruction) (Table 1). If Division of Emergency Medicine, Harvard the effusion seems to have an obvious source (e.g., in an afebrile patient with con- Medical School, Boston (T.W.T., J.D., G.S.S.). Address reprint requests to Dr. Thomsen gestive heart failure and bilateral pleural effusions), diagnostic thoracentesis may at the Department of Emergency Medi- be deferred while the underlying process is treated. The need for the procedure cine, Mount Auburn Hospital, 330 Mount should be reconsidered if there is no appropriate response to therapy.1 Auburn St., Cambridge, MA 02238, or at [email protected]. Thoracentesis, as a therapeutic procedure, may dramatically reduce respiratory distress in patients presenting with large effusions. N Engl J Med 2006;355:e16. Copyright © 2006 Massachusetts Medical Society. CONTRAINDICATIONS There are limited data on the safety of thoracentesis
    [Show full text]
  • Renovascular Hypertension
    z RENOGRAM INIS-mf —11322 RENOVASCULAR HYPERTENSION G.G. Geyskes STELLINGEN Behorende bij het proefschrift THE RENOGRAM IN RENOVASCULAR HYPERTENSION door G.G. Geyskes \ "n. it f 1 VII Het captopril renogratn kan de diagnostische PTA zoals door Maxwell Paranormale geneeskunde bij patiënten met hypertensie heeft meer bepleit vrijwel vervangen. subjectieve dan objectieve effecten. M.H. Maxwell. A.V. Walu. Hyptritnsion 1914.6:589-392. II VIII Bij dubbelzijdige nierarteriestenose geeft ncfrectomie van een kleine Het lijkt mogelijk de ontwikkeling van diabetische nefropathie af te nier in combinatie met PTA van de contralaterale nier vaak verbetering remmen door medicamenteuze antihypertensieve therapie, speciaal met van de totale nierfunktie. converting enzyme inhibitors. Ill IX Onderdrukking van de PRA is een antihyperteniief mechanisme van Het roken van sigaretten kan een oorzaak van renovaculaire hyperten- betaMokkers. sie zijn. G.G. Geyskts. J. Vos. P. Boer. E.J. Dorhoul Mets. Lmcei 1976:1049-1051. CE. Grimm el al. Nrphron 1986. 44 SI: 96-100. IV Contractie van het extracellulair volume is een antihyperteniief mecha- Het metaiodobenzylguanidine scintigram is een aanwinst bij de diag- nisme van diuretka. nostiek van het feochromocytoom. De opname van deze stof kan ook U.A.M. van Seht». G.G. Geyskti. J.C. Hom. El Dorhoul Mees. therapeutische consequenties hebben. CKn Phorm è Vier 1986. 39:6044, XI Bij veroordeling voor een /.waar misdrijf kan men 't best een levenslange Het clonidine withdrawal syndroom is een vrij sterke contraindicatie tegen het gebruik van dit antihyptttensivum. strul geven die verkort wordt bij verbetering van de mentaliteit. G.G. Geyskts. P. Boer. E.J.
    [Show full text]
  • The Care of a Patient with Fournier's Gangrene
    CASE REPORT The care of a patient with Fournier’s gangrene Esma Özşaker, Asst. Prof.,1 Meryem Yavuz, Prof.,1 Yasemin Altınbaş, MSc.,1 Burçak Şahin Köze, MSc.,1 Birgül Nurülke, MSc.2 1Department of Surgical Nursing, Ege University Faculty of Nursing, Izmir; 2Department of Urology, Ege University Faculty of Medicine Hospital, Izmir ABSTRACT Fournier’s gangrene is a rare, necrotizing fasciitis of the genitals and perineum caused by a mixture of aerobic and anaerobic microor- ganisms. This infection leads to complications including multiple organ failure and death. Due to the aggressive nature of this condition, early diagnosis is crucial. Treatment involves extensive soft tissue debridement and broad-spectrum antibiotics. Despite appropriate therapy, mortality is high. This case report aimed to present nursing approaches towards an elderly male patient referred to the urology service with a diagnosis of Fournier’s gangrene. Key words: Case report; Fournier’s gangrene; nursing diagnosis; patient care. INTRODUCTION Rarely observed in the peritoneum, genital and perianal re- perineal and genital regions, it is observed in a majority of gions, necrotizing fasciitis is named as Fournier’s gangrene.[1-5] cases with general symptoms, such as fever related infection It is an important disease, following an extremely insidious and weakness, and without symptoms in the perineal region, beginning and causing necrosis of the scrotum and penis by negatively influencing the prognosis by causing a delay in diag- advancing rapidly within one-two days.[1] The rate of mortal- nosis and treatment.[2,3] Consequently, anamnesis and physical ity in the literature is between 4 and 75%[6] and it has been examination are extremely important.
    [Show full text]